论文信息 - Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. - 字舞流文

Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

A. Lok | R. Gish | Shou-Dong Lee | R. D. de Man | Y. Chao | R. Colonno | Ting Chang | K. Han | J. Sollano | Joanna Y Yang | A. Gadano | H. Brett-Smith | Melissa Harris